A detailed history of Vestal Point Capital, LP transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 490,000 shares of RLMD stock, worth $1.35 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
490,000
Previous 1,200,000 59.17%
Holding current value
$1.35 Million
Previous $3.6 Billion 55.9%
% of portfolio
0.12%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.3 - $4.36 $1.63 Million - $3.1 Million
-710,000 Reduced 59.17%
490,000 $1.59 Billion
Q1 2024

May 13, 2024

BUY
$3.1 - $6.8 $3.36 Million - $7.38 Million
1,085,000 Added 943.48%
1,200,000 $5.58 Billion
Q4 2023

Feb 13, 2024

BUY
$2.45 - $4.22 $281,750 - $485,300
115,000 New
115,000 $476 Million

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $78.7M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.